Quantitative analysis for Ovid Therapeutics Inc. (OVID) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (65.0) (grade B). 28 signals analyzed (24 differentiated alt-data).
OVID stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $2.74 | $2.66 | $2.69 |
| 2026-05-11 | $2.91 | $2.75 | $2.79 |
| 2026-05-21 | $2.45 | $2.33 | $2.44 |
| 2026-06-03 | $2.47 | $2.32 | $2.39 |
| 2026-06-15 | $2.34 | $2.22 | $2.26 |
| 2026-06-26 | $2.60 | $2.39 | $2.55 |
| 2026-07-09 | $2.82 | $2.58 | $2.60 |
| 2026-07-21 | $2.44 | $2.29 | $2.41 |
| 2026-07-31 | $2.36 | $2.20 | $2.22 |
| 2026-08-12 | $2.65 | $2.43 | $2.62 |
| 2026-08-24 | $2.86 | $2.67 | $2.82 |
| 2026-09-03 | $2.83 | $2.73 | $2.78 |
How Ovid Therapeutics Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| NMRA | Neumora Therapeutics, Inc. Common Stock | $319M | — |
| LCTX | Lineage Cell Therapeutics, Inc. | $322M | — |
| AUNA | Auna S.A. | $324M | — |
| BCYC | Bicycle Therapeutics plc | $306M | — |
View all Health Care stocks by valuation and signals →
Ovid Therapeutics Inc. (OVID) scores Buy (65.0), with no measured dimension below 51. Its highest are competitive moat at 97, analyst consensus at 82, valuation at 72, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 97 |
| analyst consensus | 82 |
| valuation | 72 |
| technicals | 70 |
| earnings quality | 51 |
StoQuant analyzes 28 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Ovid Therapeutics Inc. (OVID): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/OVID"><img src="https://stoquant.com/badge/OVID.svg" alt="Ovid Therapeutics Inc. (OVID) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.